| Literature DB >> 29376892 |
Evi X Stavrou1,2, Chao Fang2, Kara L Bane2, Andy T Long3, Clément Naudin4, Erdem Kucukal5, Agharnan Gandhi2, Adina Brett-Morris2, Michele M Mumaw2, Sudeh Izadmehr6, Alona Merkulova2, Cindy C Reynolds2, Omar Alhalabi2, Lalitha Nayak2,7, Wen-Mei Yu2, Cheng-Kui Qu2, Howard J Meyerson8, George R Dubyak9, Umut A Gurkan5, Marvin T Nieman10, Anirban Sen Gupta11, Thomas Renné3,4, Alvin H Schmaier2,7.
Abstract
Coagulation factor XII (FXII) deficiency is associated with decreased neutrophil migration, but the mechanisms remain uncharacterized. Here, we examine how FXII contributes to the inflammatory response. In 2 models of sterile inflammation, FXII-deficient mice (F12-/-) had fewer neutrophils recruited than WT mice. We discovered that neutrophils produced a pool of FXII that is functionally distinct from hepatic-derived FXII and contributes to neutrophil trafficking at sites of inflammation. FXII signals in neutrophils through urokinase plasminogen activator receptor-mediated (uPAR-mediated) Akt2 phosphorylation at S474 (pAktS474). Downstream of pAkt2S474, FXII stimulation of neutrophils upregulated surface expression of αMβ2 integrin, increased intracellular calcium, and promoted extracellular DNA release. The sum of these activities contributed to neutrophil cell adhesion, migration, and release of neutrophil extracellular traps in a process called NETosis. Decreased neutrophil signaling in F12-/- mice resulted in less inflammation and faster wound healing. Targeting hepatic F12 with siRNA did not affect neutrophil migration, whereas WT BM transplanted into F12-/- hosts was sufficient to correct the neutrophil migration defect in F12-/- mice and restore wound inflammation. Importantly, these activities were a zymogen FXII function and independent of FXIIa and contact activation, highlighting that FXII has a sophisticated role in vivo that has not been previously appreciated.Entities:
Keywords: Cell Biology; Inflammation; Neutrophils
Mesh:
Substances:
Year: 2018 PMID: 29376892 PMCID: PMC5824869 DOI: 10.1172/JCI92880
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808